Request Quote
The official blog for all things NanoTemper

Top 5 drug discovery groups you should join on LinkedIn

2 min read
May 21, 2019

The drug discovery field is constantly evolving and it can be tough to keep up with what’s new. One of the best ways to keep up with the latest trends, read expert opinions, and meet others in working in drug discovery is by joining groups on LinkedIn. But don’t waste precious time looking for the right ones for you. Take a look below at the list below for the top 5 LinkedIn drug discovery groups you should join.


Rx&D – Biopharmaceutical, Pharmaceutical and Biotechnology Research and Development
This group has over 71,000 members and calls itself the “premier networking group specifically for research, development, scientific, technical and clinical professionals across the Pharmaceutical and Biotechnology industries.” Within this group, you can find subgroups which may fit your specific interests, including Drug Discovery, Research Technologies, Pre-Clinical Development, Clinical Research and Drug Development, Pharmacology and Pharmaceutics, Pharmacovigilance, Risk Management, and Drug Safety.


Drug Discovery & Development Professionals
This group is intended for professionals working on drug discovery or development projects. Here you can meet over 15,000 scientists and business executives that may experience challenges similar to your own and find out what solutions have worked for them.


Fragment-based Drug Discovery
Fragment-based drug discovery (FBDD) has emerged in the past decade as a powerful tool for discovering drug leads. Its innovative approach has enabled a rapid and efficient progress in drug discovery that has resulted in a constant need for information and networking within this growing scientific community. This group holds 5,000+ members and is a space for FBDD practitioners and people interested in practicing FBDD to get together and share ideas.


Oncology Drug Development
This specialized group has over 13,000 members and is designed to bring together oncology drug development professionals. Within the group, you can find scientists, investors, recruiters and clinicians from the oncology field.


Drug Design on Protein-Protein Interactions (DD-PPI)
This smaller group (1,900+ members) brings together people from experimental fields, such as biochemistry, biophysics, medicinal chemistry, pharmacology, and from in silico fields, such as bioinformatics, virtual screening, and molecular modeling. Members of this group can express their views and experiences when designing new screening assay developments, innovative chemistries, predictive models, and/or any specific properties recently discovered on PPI and their associated drug-like modulators.


That wraps up this list of the 5 LinkedIn Drug Discovery groups you should keep an eye on. Be sure to join them to stay informed and get inspired.